Filing Details

Accession Number:
0001415889-23-004564
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-08 21:34:49
Reporting Period:
2023-03-06
Accepted Time:
2023-03-08 21:34:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1597264 Blueprint Medicines Corp BPMC Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1815851 Fouad Namouni C/O Blueprint Medicines Corporation
45 Sidney Street
Cambridge MA 02139
President, R & D No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-03-06 1,885 $45.72 65,912 No 4 S Direct
Common Stock Disposition 2023-03-06 63 $44.36 65,849 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $43.96 to $44.39 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.